What changed

From · Plenary report · 1 Jul 2025 A-10-2025-0123 on the future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness

To · Adopted text · 10 Jul 2025 TA-10-2025-0165 Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness

✦ In short · AI narration of the differences below, generated 4 Sept 2026

The versions differ only in wording: a single word is removed from paragraph 34. #1

0 changes of substance, plus 1 wording-only. Each change below carries a one-line ✦ note from the same model. Written from the two texts only — read the highlighted passages before relying on it.

The changes to the text itself, in document order. Cover page, citations (“having regard to …”), standard resolution paragraphs and punctuation-only edits are left out — they are in “Show every difference”.

Show:

Change #1 Wording

Removes the word "investment" before "failure" in the phrase about reducing the cost of failure.

34. Calls for the urgent completion of the capital markets union to attract institutional investors to the biotechnology and biomanufacturing industry, including venture capital, pension funds and private equity; underlines that the sector is characterised by high levels of risk and that reducing the cost of ~~investment~~ failure in the EU is necessary for attracting large-scale capital investment; calls for dedicated support to ensure that biotechnology and biomanufacturing SMEs, start-ups and scale-ups can access sufficient funding and compete globally; stresses that cross-border investment barriers must be reduced to facilitate investment in biotechnology and biomanufacturing scale-ups;